PA-824 (Pretomanid)
Catalog No. A11401
PA-824 (Pretomanid)是一种实验性抗结核药物,MIC为<1 μg/mL。
- Wang X, .et al. Antitubercular Triazines: Optimization and Intrabacterial Metabolism, Cell Chem Biol, 2019, Nov 7. pii: S2451-9456(19)30355-1 PMID: 31711854
- Alexandre López-Gavín, .et al. In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid., Int J Antimicrob Agents., 2015, Nov;46(5):582-5 PMID: 26421981
Catalog Num | A11401 |
---|---|
M. Wt | 359.3 |
Formula | C14H12F3N3O5 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 187235-37-6 |
Synonyms | PA824 |
SMILES | C1[C@@H](COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F |
PA-824 (Pretomanid)是一种实验性抗结核药物,MIC为<1 μg/mL。
Targets
tuberculosis | ||||
In vitro (25°C) | DMSO | 64 mg/mL (178.14 mM) | |
Water | Insoluble | ||
Ethanol | 14 mg/mL (38.96 mM) | ||
In vivo | 0.5% methylcellulose | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 27.83 mL | 139.16 mL | 278.32 mL |
0.5 mM | 5.57 mL | 27.83 mL | 55.66 mL |
1 mM | 2.78 mL | 13.92 mL | 27.83 mL |
5 mM | 0.56 mL | 2.78 mL | 5.57 mL |
*The above data is based on the productmolecular weight 359.3 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.